Long-term survivor of human immunodeficiency virus-associated plasmablastic lymphoma.
Plasmablastic lymphoma (PL) is a type of non-Hodgkin's lymphoma (NHL) having a strong association with immunosuppression, especially, human immunodeficiency virus (HIV) infection. It generally has a poor prognosis with most patients dying within 2 years from initial presentation, and long-term survivors are very few. We report the case of a 10-years-old child, presenting in 2003 with swelling on the right side of the face and fever of 2 months. Evaluation revealed a mass in the right palatal and upper alveolar region with extensive spread and bone destruction, regional adenopathy, mass lesion in the liver and hepatosplenomegaly without bone marrow involvement. Histopathology was suggestive of the PL and patient tested positive for HIV. He was started on high grade NHL chemotherapy protocol along with highly-active anti-retroviral therapy HAART. He responded well and is in complete remission since 8 years of completion of treatment and is on HAART.
Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, New Delhi, India.
Atul
A
Sharma
T V S V G K
TV
Tilak
Rakesh
R
Lodha
M C
MC
Sharma
Deepak
D
Dabkara
Human immunodeficiency virus-associated non-Hodgkin's lymphoma; long-term survivor; plasmablastic lymphoma